A
Andrew J. Vickers
Researcher at Memorial Sloan Kettering Cancer Center
Publications - 865
Citations - 58362
Andrew J. Vickers is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 111, co-authored 758 publications receiving 48652 citations. Previous affiliations of Andrew J. Vickers include University of Utah & Genentech.
Papers
More filters
Journal ArticleDOI
Assessing the performance of prediction models: a framework for traditional and novel measures.
Ewout W. Steyerberg,Andrew J. Vickers,Nancy R. Cook,Thomas A. Gerds,Mithat Gonen,Nancy A Obuchowski,Michael J. Pencina,Michael W. Kattan +7 more
TL;DR: It is suggested that reporting discrimination and calibration will always be important for a prediction model and decision-analytic measures should be reported if the predictive model is to be used for clinical decisions.
Journal ArticleDOI
Decision curve analysis: a novel method for evaluating prediction models.
Andrew J. Vickers,Elena B. Elkin +1 more
TL;DR: Decision curve analysis is a suitable method for evaluating alternative diagnostic and prognostic strategies that has advantages over other commonly used measures and techniques.
Journal ArticleDOI
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.
Karel G.M. Moons,Douglas G. Altman,Johannes B. Reitsma,John P. A. Ioannidis,Petra Macaskill,Ewout W. Steyerberg,Andrew J. Vickers,David F. Ransohoff,Gary S. Collins +8 more
TL;DR: In virtually all medical domains, diagnostic and prognostic multivariable prediction models are being developed, validated, updated, and implemented with the aim to assist doctors and individuals in estimating probabilities and potentially influence their decision making.
Journal ArticleDOI
Statistics notes: Analysing controlled trials with baseline and follow up measurements.
TL;DR: In many randomised trials researchers measure a continuous variable at baseline and again as an outcome assessed at follow up to see whether a treatment can reduce pre-existing levels of pain, anxiety, hypertension, and the like.
Journal ArticleDOI
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.
William C. Huang,Andrew S. Levey,Angel M. Serio,Mark E. Snyder,Andrew J. Vickers,Ganesh V. Raj,Peter T. Scardino,Paul Russo +7 more
TL;DR: Radical nephrectomy is a significant risk factor for the development of chronic kidney disease and might no longer be regarded as the gold standard treatment for small, renal cortical tumours.